Insulin aspart, recombinant Subcutaneous and Oxymorphone Injection
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Oxymorphone Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: oxymorphone
Brand name: Opana, Opana ER, Numorphan HCl
Synonyms: Oxymorphone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Oxymorphone Tablets
- Insulin aspart, recombinant Subcutaneous-Oxytocin
- Insulin aspart, recombinant Subcutaneous-Oxytocin Intravenous, Intramuscular
- Insulin aspart, recombinant Subcutaneous-Oxytrol
- Insulin aspart, recombinant Subcutaneous-Oystercal-D
- Insulin aspart, recombinant Subcutaneous-Ozempic
- Oxymorphone Injection-Insulin degludec
- Oxymorphone Injection-Insulin Degludec (U-100) Prefilled Pens
- Oxymorphone Injection-Insulin Degludec (U-100) Vials
- Oxymorphone Injection-Insulin Degludec (U-200) Prefilled Pens
- Oxymorphone Injection-Insulin degludec and liraglutide
- Oxymorphone Injection-Insulin degludec and liraglutide Subcutaneous